Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis

Hepatology

Volumn 48, Issue 2, 2008, Pages 442-448

  Nobili, Valerio ^a   Vizzutti, Francesco ^b   Arena, Umberto ^b   Abraldes, Juan G ^c   Marra, Fabio ^b   Pietrobattista, Andrea ^a   Fruhwirth, Rodolfo ^a   Marcellini, Matilde ^a   Pinzani, Massimo ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRAMADOL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELASTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SHOULDER PAIN; SINGLE DRUG DOSE; STAGING;

ADOLESCENT; CHILD; COHORT STUDIES; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS; MALE; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 49649105500     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22376     Document Type: Article

References (32)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-2850.
2. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-2009.
3. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118: 1388-1393.
4. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28:1257-1263.
5. Adams LA, Lymp JF, St. Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of non-alcoholic fatty liver disease a population-based cohort study. Gastroenterology 2005;129:113-121.
6. Ekstedt M, Franzen LE, Mathiensen UI, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. HEPATOLOGY 2006;44:865-873.
7. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunelle, F, Carucci P, et al. Expanding the natural history of non-alcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
8. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gatroenterol Nutr 1984;3:408-414.
9. Jankowska I, Socha P, Pawlowska J, Teisseyre M, Gliwicz D, Czubkowski P, et al. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. Pediatr Transplant 2007;11:796-798.
10. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of non-alcoholic fatty liver disease: A longitudinally study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-138.
11. Pinzani M, Vizzutti F, Arena U, Marra F. Technology Insight: non-invasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008;5:95-106.
12. Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371-378.
13. de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using fibroscan: Feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutt 2007;45:443-450.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatic model assessment: Insulin resistance and beta-cell function from fasting glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
15. Matsuda M, De Fronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
16. Sharma P, MacDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: Relation to platelet count. J Clin Gastroenterol 1982;4: 451-453.
17. Cassiman D, Jaeken J. NASH may be trash. Gut 2008;57:141-143.
18. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice. HEPATOLOGY 2006;44:458-465.
19. Nobili V, Comparcola D, Sartorelli MR, Natali G, Monti L, Falappa P, et al. Blind and ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol 2003;33:772-775.
20. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
21. Ziol M, Handra-Luca A, Kertaneh A, Christidis C, Mal F, Kazemi F, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005;41:48-54.
22. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastometry, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.
23. Bewick V, Cheek L, Ball J. Statistics review 9: One-way analysis of variance. Crit Care 2004;8:130-136.
24. Guyart G, Sackett DL, Haynes B. Evaluating diagnostic test. In: Haynes B, Sackett DL, Guyatt G, Tulliez M, eds. Clinical Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006:273-322.
25. Decks JJ, Altman DG. Diagnostic tests 4: Likelihood ratios. BMJ 2004; 329:168-169.
26. Sterne JA, Davey SG. Sifting the evidence-what's wrong with significance tests? BMJ 2001;322:226-231.
27. Garr JJ, Nam J. Approximate interval estimation of the ratio of binomial parameters: A review and correction for skewness. Biometrics 1988;44:323-338.
28. Bartko JJ. Measures of agreement: A single procedure. Star Med 1994;13:737-745.
29. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial. HEPATOLOGY 2008; doi:10.1002/hep.22336.
30. Angulo P. Nonalcoholic fatty liver disease, N Engl J Med 2002;346:1221-1231.
31. Sandrin L, Fourquet B, Haquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713.
32. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-973.